Pdt Partners, LLC Rhythm Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $414,860 - $539,267	-17,207 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$26.99 - $35.85 $598,989 - $795,619	-22,193 Reduced 56.33%	17,207 $502,000
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $28,814 - $59,593	1,693 Added 4.49%	39,400 $1.23 Million
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $750,369 - $1.22 Million	37,707 New	37,707 $750,000

176

62.4M

880K

84.1K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.36B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.